Psychotic Disorders
16 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Mental Disorders
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Aripiprazole for psychotic disorders | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cannabidiol for psychotic disorders | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Cognitive Training for psychotic disorders | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cognitive Training + Personalized neuroprotective strategies : Vitamin B12, folinic acid, Omega 3, NAC for psychotic disorders | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Group Therapy Program for psychotic disorders | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Group Therapy Program + naltrexone and bupropion (combination) for psychotic disorders | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Group Therapy Program + Phentermine-Topiramate for psychotic disorders | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Group Therapy Program + Semaglutide for psychotic disorders | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ketogenic Diet for psychotic disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ketogenic diet intervention for psychotic disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ML-007C-MA for psychotic disorders | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Navigate for psychotic disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Personalized neuroprotective strategies : Vitamin B12, folinic acid, Omega 3, NAC for psychotic disorders | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Risperidone for psychotic disorders | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Rituximab for psychotic disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| TAU+CBT for pts+Family Intervention+CM. for psychotic disorders | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.